http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6591768

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 442
issn 1837-9664
pageRange 435-442
publicationName Journal of Cancer
startingPage 435
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_86685a9664c0822f1b82d56fd155fd29
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_77f8a4ac1202c0f1378fb83c4f06641c
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b547d917d2bedf9697bcca2c17940044
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_26ce7d78db467829f488ccea3dbca022
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a358efad4acf82adfac6bf0b9934deca
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab80a732b5df33e85751c0a758afb577
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4d6691528c28b8ac2498a98954cdf15f
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1d5440abe078342d6b8671b97f137e6f
bibliographicCitation Bartholomeusz C, Yamasaki F, Saso H, Kurisu K, Hortobagyi GN, Ueno NT. Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt. J Cancer. 2011;2():435–42. PMID: 21850211; PMCID: PMC3157020.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1df61c6533f6560c331a3336197156e6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80f8b075eb744101aa26f213ced047fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8cffa9e5bf6e513fd1adc8fbcfaf4dba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4be01a9bfe9875f3e99e880a060d6b35
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0164-6295
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce4a184ed7e4452fcf14a5829725d9be
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_beb2de6b3bf42c53b5c3def48b8aca16
date 2011
identifier https://pubmed.ncbi.nlm.nih.gov/21850211
https://doi.org/10.7150/jca.2.435
https://pubmed.ncbi.nlm.nih.gov/PMC3157020
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37885
https://portal.issn.org/resource/ISSN/1837-9664
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bcd6f21312d21a5cf3f0a82f59d9ac97
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128141778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128074998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129334556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135897353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127899424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127983340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 57.